机构：[1]Division of Nephrology and Kidney Research Institute, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, 610041 Chengdu, Sichuan, China四川大学华西医院
This work was supported by the National Natural Science Foundation of China
(32070049), Science and Technology department of Sichuan Province 2020YJ0208,
and the China Postdoctoral Science Foundation BX20220219.
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2022]版：
大类|1 区医学
小类|1 区生化与分子生物学1 区细胞生物学
最新[2023]版：
大类|1 区医学
小类|1 区生化与分子生物学1 区细胞生物学
第一作者：
第一作者机构：[1]Division of Nephrology and Kidney Research Institute, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, 610041 Chengdu, Sichuan, China
通讯作者：
推荐引用方式(GB/T 7714)：
Xu Zheng,Shao Zhenhua.Dynamic mechanism of GPCR-mediated β-arrestin: a potential therapeutic agent discovery of biased drug[J].Signal transduction and targeted therapy.2022,7(1):283.doi:10.1038/s41392-022-01140-6.
APA：
Xu Zheng&Shao Zhenhua.(2022).Dynamic mechanism of GPCR-mediated β-arrestin: a potential therapeutic agent discovery of biased drug.Signal transduction and targeted therapy,7,(1)
MLA：
Xu Zheng,et al."Dynamic mechanism of GPCR-mediated β-arrestin: a potential therapeutic agent discovery of biased drug".Signal transduction and targeted therapy 7..1(2022):283
医学